nodes	percent_of_prediction	percent_of_DWPC	metapath
Estazolam—Clobazam—SLC6A11—melanoma	0.0192	0.765	CrCbGaD
Estazolam—GABRR3—eye—melanoma	0.00794	0.0689	CbGeAlD
Estazolam—GABRR3—retina—melanoma	0.00787	0.0683	CbGeAlD
Estazolam—GABRE—hair follicle—melanoma	0.00737	0.0639	CbGeAlD
Estazolam—GABRR2—eye—melanoma	0.00689	0.0597	CbGeAlD
Estazolam—GABRR2—retina—melanoma	0.00682	0.0592	CbGeAlD
Estazolam—GABRA3—neck—melanoma	0.00669	0.058	CbGeAlD
Estazolam—GABRR1—eye—melanoma	0.00663	0.0575	CbGeAlD
Estazolam—GABRR1—retina—melanoma	0.00657	0.057	CbGeAlD
Estazolam—Coordination abnormal—Temozolomide—melanoma	0.00608	0.00754	CcSEcCtD
Estazolam—Urinary incontinence—Carmustine—melanoma	0.00596	0.0074	CcSEcCtD
Estazolam—Depressed level of consciousness—Carmustine—melanoma	0.00596	0.0074	CcSEcCtD
Estazolam—Urinary incontinence—Temozolomide—melanoma	0.00576	0.00715	CcSEcCtD
Estazolam—Depressed level of consciousness—Temozolomide—melanoma	0.00576	0.00715	CcSEcCtD
Estazolam—Erythema multiforme—Vemurafenib—melanoma	0.00554	0.00688	CcSEcCtD
Estazolam—Abnormal vision—Carmustine—melanoma	0.00539	0.00668	CcSEcCtD
Estazolam—Mental disability—Carmustine—melanoma	0.00536	0.00665	CcSEcCtD
Estazolam—Neuritis—Docetaxel—melanoma	0.00532	0.0066	CcSEcCtD
Estazolam—Arthritis—Bleomycin—melanoma	0.00528	0.00656	CcSEcCtD
Estazolam—Chills—Vemurafenib—melanoma	0.00526	0.00653	CcSEcCtD
Estazolam—Scotoma—Docetaxel—melanoma	0.00523	0.00649	CcSEcCtD
Estazolam—Abnormal vision—Temozolomide—melanoma	0.0052	0.00646	CcSEcCtD
Estazolam—Mental disability—Temozolomide—melanoma	0.00518	0.00643	CcSEcCtD
Estazolam—Malnutrition—Vemurafenib—melanoma	0.0051	0.00634	CcSEcCtD
Estazolam—Ear pain—Temozolomide—melanoma	0.00508	0.0063	CcSEcCtD
Estazolam—Eye pain—Carmustine—melanoma	0.00497	0.00616	CcSEcCtD
Estazolam—Back pain—Vemurafenib—melanoma	0.00494	0.00613	CcSEcCtD
Estazolam—Vascular purpura—Temozolomide—melanoma	0.00484	0.00601	CcSEcCtD
Estazolam—Eye pain—Temozolomide—melanoma	0.0048	0.00596	CcSEcCtD
Estazolam—Amnesia—Carmustine—melanoma	0.00477	0.00592	CcSEcCtD
Estazolam—Eye irritation—Docetaxel—melanoma	0.00465	0.00577	CcSEcCtD
Estazolam—Amnesia—Temozolomide—melanoma	0.00461	0.00572	CcSEcCtD
Estazolam—Thirst—Temozolomide—melanoma	0.00455	0.00565	CcSEcCtD
Estazolam—GABRR3—head—melanoma	0.00451	0.0391	CbGeAlD
Estazolam—Purpura—Temozolomide—melanoma	0.00449	0.00558	CcSEcCtD
Estazolam—Diplopia—Carmustine—melanoma	0.00448	0.00556	CcSEcCtD
Estazolam—Cough—Vemurafenib—melanoma	0.00445	0.00553	CcSEcCtD
Estazolam—Myalgia—Vemurafenib—melanoma	0.00435	0.00539	CcSEcCtD
Estazolam—Arthralgia—Vemurafenib—melanoma	0.00435	0.00539	CcSEcCtD
Estazolam—Diplopia—Temozolomide—melanoma	0.00433	0.00538	CcSEcCtD
Estazolam—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.00431	0.00535	CcSEcCtD
Estazolam—Oliguria—Docetaxel—melanoma	0.00431	0.00534	CcSEcCtD
Estazolam—Affect lability—Temozolomide—melanoma	0.00426	0.00529	CcSEcCtD
Estazolam—Ataxia—Carmustine—melanoma	0.00422	0.00523	CcSEcCtD
Estazolam—Hearing impaired—Docetaxel—melanoma	0.00417	0.00517	CcSEcCtD
Estazolam—Mood swings—Temozolomide—melanoma	0.0041	0.00509	CcSEcCtD
Estazolam—Ataxia—Temozolomide—melanoma	0.00407	0.00506	CcSEcCtD
Estazolam—Weight decreased—Bleomycin—melanoma	0.00402	0.00498	CcSEcCtD
Estazolam—Dry skin—Temozolomide—melanoma	0.00397	0.00493	CcSEcCtD
Estazolam—GABRG3—head—melanoma	0.00395	0.0342	CbGeAlD
Estazolam—GABRR2—head—melanoma	0.00391	0.0339	CbGeAlD
Estazolam—Aspartate aminotransferase increased—Temozolomide—melanoma	0.0039	0.00484	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Vemurafenib—melanoma	0.0038	0.00471	CcSEcCtD
Estazolam—Haematuria—Bleomycin—melanoma	0.00377	0.00468	CcSEcCtD
Estazolam—GABRR1—head—melanoma	0.00376	0.0326	CbGeAlD
Estazolam—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.00366	0.00454	CcSEcCtD
Estazolam—Decreased appetite—Vemurafenib—melanoma	0.00362	0.00449	CcSEcCtD
Estazolam—Constipation—Vemurafenib—melanoma	0.00356	0.00442	CcSEcCtD
Estazolam—Pollakiuria—Temozolomide—melanoma	0.00346	0.00429	CcSEcCtD
Estazolam—Depression—Carmustine—melanoma	0.00344	0.00427	CcSEcCtD
Estazolam—Agranulocytosis—Dactinomycin—melanoma	0.00344	0.00427	CcSEcCtD
Estazolam—Photosensitivity reaction—Temozolomide—melanoma	0.00342	0.00424	CcSEcCtD
Estazolam—Weight increased—Temozolomide—melanoma	0.00341	0.00423	CcSEcCtD
Estazolam—Weight decreased—Temozolomide—melanoma	0.00339	0.0042	CcSEcCtD
Estazolam—Neuropathy peripheral—Carmustine—melanoma	0.00339	0.0042	CcSEcCtD
Estazolam—Depression—Temozolomide—melanoma	0.00333	0.00413	CcSEcCtD
Estazolam—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00331	0.00411	CcSEcCtD
Estazolam—Flushing—Bleomycin—melanoma	0.0033	0.00409	CcSEcCtD
Estazolam—Body temperature increased—Vemurafenib—melanoma	0.00329	0.00409	CcSEcCtD
Estazolam—Pharyngitis—Dactinomycin—melanoma	0.00329	0.00408	CcSEcCtD
Estazolam—Neuropathy peripheral—Temozolomide—melanoma	0.00327	0.00406	CcSEcCtD
Estazolam—GABRD—head—melanoma	0.00327	0.0284	CbGeAlD
Estazolam—Chills—Bleomycin—melanoma	0.00319	0.00396	CcSEcCtD
Estazolam—GABRG1—head—melanoma	0.00315	0.0273	CbGeAlD
Estazolam—Erythema multiforme—Dactinomycin—melanoma	0.00313	0.00389	CcSEcCtD
Estazolam—Sinusitis—Temozolomide—melanoma	0.00313	0.00389	CcSEcCtD
Estazolam—GABRB3—eye—melanoma	0.00312	0.027	CbGeAlD
Estazolam—Hallucination—Carmustine—melanoma	0.00309	0.00383	CcSEcCtD
Estazolam—Flushing—Dactinomycin—melanoma	0.00308	0.00382	CcSEcCtD
Estazolam—Hypersensitivity—Vemurafenib—melanoma	0.00307	0.00381	CcSEcCtD
Estazolam—GABRB1—head—melanoma	0.00305	0.0265	CbGeAlD
Estazolam—GABRA5—head—melanoma	0.00304	0.0263	CbGeAlD
Estazolam—Asthenia—Vemurafenib—melanoma	0.00299	0.00371	CcSEcCtD
Estazolam—Visual impairment—Carmustine—melanoma	0.00299	0.00371	CcSEcCtD
Estazolam—Hallucination—Temozolomide—melanoma	0.00298	0.0037	CcSEcCtD
Estazolam—Pharyngitis—Temozolomide—melanoma	0.00297	0.00369	CcSEcCtD
Estazolam—Chills—Dactinomycin—melanoma	0.00297	0.00369	CcSEcCtD
Estazolam—Pruritus—Vemurafenib—melanoma	0.00295	0.00366	CcSEcCtD
Estazolam—GABRE—mammalian vulva—melanoma	0.00292	0.0253	CbGeAlD
Estazolam—Visual impairment—Temozolomide—melanoma	0.00289	0.00358	CcSEcCtD
Estazolam—Pain in extremity—Docetaxel—melanoma	0.00288	0.00358	CcSEcCtD
Estazolam—Flushing—Carmustine—melanoma	0.00288	0.00357	CcSEcCtD
Estazolam—Ill-defined disorder—Bleomycin—melanoma	0.00287	0.00356	CcSEcCtD
Estazolam—Erythema multiforme—Temozolomide—melanoma	0.00283	0.00352	CcSEcCtD
Estazolam—GABRA3—head—melanoma	0.00283	0.0245	CbGeAlD
Estazolam—Tinnitus—Temozolomide—melanoma	0.00279	0.00347	CcSEcCtD
Estazolam—Malaise—Bleomycin—melanoma	0.00279	0.00346	CcSEcCtD
Estazolam—Flushing—Temozolomide—melanoma	0.00278	0.00345	CcSEcCtD
Estazolam—Arrhythmia—Carmustine—melanoma	0.00277	0.00344	CcSEcCtD
Estazolam—Leukopenia—Bleomycin—melanoma	0.00277	0.00344	CcSEcCtD
Estazolam—Dizziness—Vemurafenib—melanoma	0.00275	0.00342	CcSEcCtD
Estazolam—GABRR2—lymph node—melanoma	0.00274	0.0237	CbGeAlD
Estazolam—GABRP—head—melanoma	0.00273	0.0237	CbGeAlD
Estazolam—Ataxia—Docetaxel—melanoma	0.00271	0.00336	CcSEcCtD
Estazolam—Malnutrition—Carmustine—melanoma	0.0027	0.00335	CcSEcCtD
Estazolam—Cough—Bleomycin—melanoma	0.0027	0.00335	CcSEcCtD
Estazolam—Chills—Temozolomide—melanoma	0.00269	0.00334	CcSEcCtD
Estazolam—Ill-defined disorder—Dactinomycin—melanoma	0.00268	0.00332	CcSEcCtD
Estazolam—Vomiting—Vemurafenib—melanoma	0.00265	0.00329	CcSEcCtD
Estazolam—Dry skin—Docetaxel—melanoma	0.00264	0.00328	CcSEcCtD
Estazolam—Chest pain—Bleomycin—melanoma	0.00263	0.00327	CcSEcCtD
Estazolam—Myalgia—Bleomycin—melanoma	0.00263	0.00327	CcSEcCtD
Estazolam—Rash—Vemurafenib—melanoma	0.00263	0.00326	CcSEcCtD
Estazolam—Dermatitis—Vemurafenib—melanoma	0.00262	0.00326	CcSEcCtD
Estazolam—Back pain—Carmustine—melanoma	0.00261	0.00324	CcSEcCtD
Estazolam—Headache—Vemurafenib—melanoma	0.00261	0.00324	CcSEcCtD
Estazolam—Malnutrition—Temozolomide—melanoma	0.00261	0.00324	CcSEcCtD
Estazolam—Discomfort—Bleomycin—melanoma	0.0026	0.00323	CcSEcCtD
Estazolam—Malaise—Dactinomycin—melanoma	0.0026	0.00323	CcSEcCtD
Estazolam—Aspartate aminotransferase increased—Docetaxel—melanoma	0.00259	0.00322	CcSEcCtD
Estazolam—Leukopenia—Dactinomycin—melanoma	0.00258	0.0032	CcSEcCtD
Estazolam—Nasopharyngitis—Docetaxel—melanoma	0.00258	0.0032	CcSEcCtD
Estazolam—Confusional state—Bleomycin—melanoma	0.00254	0.00316	CcSEcCtD
Estazolam—Tremor—Carmustine—melanoma	0.00253	0.00314	CcSEcCtD
Estazolam—Oedema—Bleomycin—melanoma	0.00252	0.00313	CcSEcCtD
Estazolam—Back pain—Temozolomide—melanoma	0.00252	0.00313	CcSEcCtD
Estazolam—Agitation—Carmustine—melanoma	0.00248	0.00308	CcSEcCtD
Estazolam—Nausea—Vemurafenib—melanoma	0.00247	0.00307	CcSEcCtD
Estazolam—Myalgia—Dactinomycin—melanoma	0.00246	0.00305	CcSEcCtD
Estazolam—Tremor—Temozolomide—melanoma	0.00244	0.00303	CcSEcCtD
Estazolam—Discomfort—Dactinomycin—melanoma	0.00243	0.00301	CcSEcCtD
Estazolam—Ill-defined disorder—Temozolomide—melanoma	0.00242	0.003	CcSEcCtD
Estazolam—Leukopenia—Carmustine—melanoma	0.00242	0.003	CcSEcCtD
Estazolam—Agitation—Temozolomide—melanoma	0.0024	0.00298	CcSEcCtD
Estazolam—Oedema—Dactinomycin—melanoma	0.00235	0.00292	CcSEcCtD
Estazolam—Malaise—Temozolomide—melanoma	0.00235	0.00292	CcSEcCtD
Estazolam—Convulsion—Carmustine—melanoma	0.00234	0.0029	CcSEcCtD
Estazolam—Leukopenia—Temozolomide—melanoma	0.00234	0.0029	CcSEcCtD
Estazolam—Palpitations—Temozolomide—melanoma	0.00231	0.00286	CcSEcCtD
Estazolam—GABRB2—head—melanoma	0.0023	0.02	CbGeAlD
Estazolam—GABRG2—head—melanoma	0.0023	0.02	CbGeAlD
Estazolam—Musculoskeletal discomfort—Bleomycin—melanoma	0.0023	0.00285	CcSEcCtD
Estazolam—Chest pain—Carmustine—melanoma	0.0023	0.00285	CcSEcCtD
Estazolam—Myalgia—Carmustine—melanoma	0.0023	0.00285	CcSEcCtD
Estazolam—Anxiety—Carmustine—melanoma	0.00229	0.00284	CcSEcCtD
Estazolam—Cough—Temozolomide—melanoma	0.00228	0.00283	CcSEcCtD
Estazolam—Paraesthesia—Bleomycin—melanoma	0.00227	0.00281	CcSEcCtD
Estazolam—Weight increased—Docetaxel—melanoma	0.00227	0.00281	CcSEcCtD
Estazolam—Convulsion—Temozolomide—melanoma	0.00226	0.00281	CcSEcCtD
Estazolam—Weight decreased—Docetaxel—melanoma	0.00225	0.0028	CcSEcCtD
Estazolam—Dyspnoea—Bleomycin—melanoma	0.00225	0.00279	CcSEcCtD
Estazolam—Confusional state—Carmustine—melanoma	0.00222	0.00276	CcSEcCtD
Estazolam—Myalgia—Temozolomide—melanoma	0.00222	0.00276	CcSEcCtD
Estazolam—Arthralgia—Temozolomide—melanoma	0.00222	0.00276	CcSEcCtD
Estazolam—Anxiety—Temozolomide—melanoma	0.00221	0.00275	CcSEcCtD
Estazolam—Oedema—Carmustine—melanoma	0.0022	0.00273	CcSEcCtD
Estazolam—Stevens-Johnson syndrome—Docetaxel—melanoma	0.0022	0.00273	CcSEcCtD
Estazolam—Discomfort—Temozolomide—melanoma	0.00219	0.00272	CcSEcCtD
Estazolam—Decreased appetite—Bleomycin—melanoma	0.00219	0.00272	CcSEcCtD
Estazolam—Neuropathy peripheral—Docetaxel—melanoma	0.00218	0.0027	CcSEcCtD
Estazolam—Dry mouth—Temozolomide—melanoma	0.00217	0.0027	CcSEcCtD
Estazolam—Pain—Bleomycin—melanoma	0.00216	0.00268	CcSEcCtD
Estazolam—Confusional state—Temozolomide—melanoma	0.00215	0.00266	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00214	0.00266	CcSEcCtD
Estazolam—Oedema—Temozolomide—melanoma	0.00213	0.00264	CcSEcCtD
Estazolam—GABRA2—head—melanoma	0.0021	0.0183	CbGeAlD
Estazolam—Epistaxis—Docetaxel—melanoma	0.00209	0.0026	CcSEcCtD
Estazolam—GABRE—head—melanoma	0.00209	0.0181	CbGeAlD
Estazolam—Feeling abnormal—Bleomycin—melanoma	0.00208	0.00258	CcSEcCtD
Estazolam—Agranulocytosis—Docetaxel—melanoma	0.00207	0.00257	CcSEcCtD
Estazolam—Hyperhidrosis—Temozolomide—melanoma	0.00206	0.00255	CcSEcCtD
Estazolam—Decreased appetite—Dactinomycin—melanoma	0.00205	0.00254	CcSEcCtD
Estazolam—GABRA1—head—melanoma	0.00203	0.0176	CbGeAlD
Estazolam—Pain—Dactinomycin—melanoma	0.00201	0.0025	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Carmustine—melanoma	0.00201	0.00249	CcSEcCtD
Estazolam—Urticaria—Bleomycin—melanoma	0.00201	0.00249	CcSEcCtD
Estazolam—Rhinitis—Docetaxel—melanoma	0.002	0.00248	CcSEcCtD
Estazolam—Body temperature increased—Bleomycin—melanoma	0.002	0.00248	CcSEcCtD
Estazolam—Paraesthesia—Carmustine—melanoma	0.00198	0.00246	CcSEcCtD
Estazolam—Pharyngitis—Docetaxel—melanoma	0.00198	0.00245	CcSEcCtD
Estazolam—Dyspnoea—Carmustine—melanoma	0.00196	0.00244	CcSEcCtD
Estazolam—Somnolence—Carmustine—melanoma	0.00196	0.00243	CcSEcCtD
Estazolam—Feeling abnormal—Dactinomycin—melanoma	0.00194	0.00241	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Temozolomide—melanoma	0.00194	0.00241	CcSEcCtD
Estazolam—Gastrointestinal pain—Dactinomycin—melanoma	0.00192	0.00239	CcSEcCtD
Estazolam—Visual impairment—Docetaxel—melanoma	0.00192	0.00238	CcSEcCtD
Estazolam—Decreased appetite—Carmustine—melanoma	0.00192	0.00238	CcSEcCtD
Estazolam—Paraesthesia—Temozolomide—melanoma	0.00191	0.00237	CcSEcCtD
Estazolam—Dyspnoea—Temozolomide—melanoma	0.0019	0.00236	CcSEcCtD
Estazolam—Somnolence—Temozolomide—melanoma	0.00189	0.00235	CcSEcCtD
Estazolam—Erythema multiforme—Docetaxel—melanoma	0.00188	0.00234	CcSEcCtD
Estazolam—Constipation—Carmustine—melanoma	0.00188	0.00234	CcSEcCtD
Estazolam—Pain—Carmustine—melanoma	0.00188	0.00234	CcSEcCtD
Estazolam—Dyspepsia—Temozolomide—melanoma	0.00187	0.00233	CcSEcCtD
Estazolam—Body temperature increased—Dactinomycin—melanoma	0.00186	0.00231	CcSEcCtD
Estazolam—Abdominal pain—Dactinomycin—melanoma	0.00186	0.00231	CcSEcCtD
Estazolam—Hypersensitivity—Bleomycin—melanoma	0.00186	0.00231	CcSEcCtD
Estazolam—Decreased appetite—Temozolomide—melanoma	0.00185	0.0023	CcSEcCtD
Estazolam—Flushing—Docetaxel—melanoma	0.00185	0.0023	CcSEcCtD
Estazolam—Pain—Temozolomide—melanoma	0.00182	0.00226	CcSEcCtD
Estazolam—Constipation—Temozolomide—melanoma	0.00182	0.00226	CcSEcCtD
Estazolam—Feeling abnormal—Carmustine—melanoma	0.00182	0.00225	CcSEcCtD
Estazolam—Asthenia—Bleomycin—melanoma	0.00181	0.00225	CcSEcCtD
Estazolam—Gastrointestinal pain—Carmustine—melanoma	0.0018	0.00224	CcSEcCtD
Estazolam—Chills—Docetaxel—melanoma	0.00179	0.00222	CcSEcCtD
Estazolam—Pruritus—Bleomycin—melanoma	0.00179	0.00222	CcSEcCtD
Estazolam—Arrhythmia—Docetaxel—melanoma	0.00178	0.00221	CcSEcCtD
Estazolam—GABRB3—head—melanoma	0.00177	0.0153	CbGeAlD
Estazolam—Feeling abnormal—Temozolomide—melanoma	0.00175	0.00218	CcSEcCtD
Estazolam—Body temperature increased—Carmustine—melanoma	0.00174	0.00216	CcSEcCtD
Estazolam—Abdominal pain—Carmustine—melanoma	0.00174	0.00216	CcSEcCtD
Estazolam—Gastrointestinal pain—Temozolomide—melanoma	0.00174	0.00216	CcSEcCtD
Estazolam—Malnutrition—Docetaxel—melanoma	0.00173	0.00215	CcSEcCtD
Estazolam—Hypersensitivity—Dactinomycin—melanoma	0.00173	0.00215	CcSEcCtD
Estazolam—Urticaria—Temozolomide—melanoma	0.00169	0.0021	CcSEcCtD
Estazolam—Asthenia—Dactinomycin—melanoma	0.00169	0.0021	CcSEcCtD
Estazolam—Body temperature increased—Temozolomide—melanoma	0.00168	0.00209	CcSEcCtD
Estazolam—Abdominal pain—Temozolomide—melanoma	0.00168	0.00209	CcSEcCtD
Estazolam—Back pain—Docetaxel—melanoma	0.00168	0.00208	CcSEcCtD
Estazolam—Muscle spasms—Docetaxel—melanoma	0.00167	0.00207	CcSEcCtD
Estazolam—Hypersensitivity—Carmustine—melanoma	0.00162	0.00201	CcSEcCtD
Estazolam—Vomiting—Bleomycin—melanoma	0.0016	0.00199	CcSEcCtD
Estazolam—Rash—Bleomycin—melanoma	0.00159	0.00198	CcSEcCtD
Estazolam—Dermatitis—Bleomycin—melanoma	0.00159	0.00197	CcSEcCtD
Estazolam—Asthenia—Carmustine—melanoma	0.00158	0.00196	CcSEcCtD
Estazolam—Hypersensitivity—Temozolomide—melanoma	0.00157	0.00195	CcSEcCtD
Estazolam—Syncope—Docetaxel—melanoma	0.00156	0.00193	CcSEcCtD
Estazolam—Leukopenia—Docetaxel—melanoma	0.00155	0.00193	CcSEcCtD
Estazolam—Palpitations—Docetaxel—melanoma	0.00153	0.0019	CcSEcCtD
Estazolam—Asthenia—Temozolomide—melanoma	0.00153	0.0019	CcSEcCtD
Estazolam—Loss of consciousness—Docetaxel—melanoma	0.00152	0.00189	CcSEcCtD
Estazolam—Cough—Docetaxel—melanoma	0.00151	0.00188	CcSEcCtD
Estazolam—Pruritus—Temozolomide—melanoma	0.00151	0.00187	CcSEcCtD
Estazolam—Convulsion—Docetaxel—melanoma	0.0015	0.00187	CcSEcCtD
Estazolam—Nausea—Bleomycin—melanoma	0.0015	0.00186	CcSEcCtD
Estazolam—Vomiting—Dactinomycin—melanoma	0.0015	0.00186	CcSEcCtD
Estazolam—Rash—Dactinomycin—melanoma	0.00148	0.00184	CcSEcCtD
Estazolam—Arthralgia—Docetaxel—melanoma	0.00148	0.00183	CcSEcCtD
Estazolam—Myalgia—Docetaxel—melanoma	0.00148	0.00183	CcSEcCtD
Estazolam—Chest pain—Docetaxel—melanoma	0.00148	0.00183	CcSEcCtD
Estazolam—GABRA2—lymph node—melanoma	0.00147	0.0128	CbGeAlD
Estazolam—GABRE—lymph node—melanoma	0.00146	0.0127	CbGeAlD
Estazolam—Dizziness—Carmustine—melanoma	0.00146	0.00181	CcSEcCtD
Estazolam—Dry mouth—Docetaxel—melanoma	0.00144	0.00179	CcSEcCtD
Estazolam—Confusional state—Docetaxel—melanoma	0.00143	0.00177	CcSEcCtD
Estazolam—Oedema—Docetaxel—melanoma	0.00142	0.00176	CcSEcCtD
Estazolam—Dizziness—Temozolomide—melanoma	0.00141	0.00175	CcSEcCtD
Estazolam—Vomiting—Carmustine—melanoma	0.0014	0.00174	CcSEcCtD
Estazolam—Nausea—Dactinomycin—melanoma	0.0014	0.00174	CcSEcCtD
Estazolam—Shock—Docetaxel—melanoma	0.00139	0.00173	CcSEcCtD
Estazolam—Rash—Carmustine—melanoma	0.00139	0.00172	CcSEcCtD
Estazolam—Dermatitis—Carmustine—melanoma	0.00139	0.00172	CcSEcCtD
Estazolam—Headache—Carmustine—melanoma	0.00138	0.00171	CcSEcCtD
Estazolam—Vomiting—Temozolomide—melanoma	0.00135	0.00168	CcSEcCtD
Estazolam—Rash—Temozolomide—melanoma	0.00134	0.00167	CcSEcCtD
Estazolam—Dermatitis—Temozolomide—melanoma	0.00134	0.00166	CcSEcCtD
Estazolam—Headache—Temozolomide—melanoma	0.00133	0.00166	CcSEcCtD
Estazolam—Nausea—Carmustine—melanoma	0.00131	0.00162	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Docetaxel—melanoma	0.00129	0.0016	CcSEcCtD
Estazolam—Paraesthesia—Docetaxel—melanoma	0.00127	0.00158	CcSEcCtD
Estazolam—Nausea—Temozolomide—melanoma	0.00126	0.00157	CcSEcCtD
Estazolam—Dyspnoea—Docetaxel—melanoma	0.00126	0.00157	CcSEcCtD
Estazolam—Somnolence—Docetaxel—melanoma	0.00126	0.00156	CcSEcCtD
Estazolam—Dyspepsia—Docetaxel—melanoma	0.00125	0.00155	CcSEcCtD
Estazolam—Decreased appetite—Docetaxel—melanoma	0.00123	0.00153	CcSEcCtD
Estazolam—Pain—Docetaxel—melanoma	0.00121	0.0015	CcSEcCtD
Estazolam—Constipation—Docetaxel—melanoma	0.00121	0.0015	CcSEcCtD
Estazolam—Feeling abnormal—Docetaxel—melanoma	0.00117	0.00145	CcSEcCtD
Estazolam—Gastrointestinal pain—Docetaxel—melanoma	0.00116	0.00144	CcSEcCtD
Estazolam—Abdominal pain—Docetaxel—melanoma	0.00112	0.00139	CcSEcCtD
Estazolam—Body temperature increased—Docetaxel—melanoma	0.00112	0.00139	CcSEcCtD
Estazolam—Hypersensitivity—Docetaxel—melanoma	0.00104	0.00129	CcSEcCtD
Estazolam—Ketazolam—ALB—melanoma	0.00102	0.0408	CrCbGaD
Estazolam—Asthenia—Docetaxel—melanoma	0.00102	0.00126	CcSEcCtD
Estazolam—Pruritus—Docetaxel—melanoma	0.001	0.00124	CcSEcCtD
Estazolam—Ketazolam—ABCB1—melanoma	0.000976	0.0389	CrCbGaD
Estazolam—Dizziness—Docetaxel—melanoma	0.000936	0.00116	CcSEcCtD
Estazolam—Vomiting—Docetaxel—melanoma	0.0009	0.00112	CcSEcCtD
Estazolam—Rash—Docetaxel—melanoma	0.000893	0.00111	CcSEcCtD
Estazolam—Dermatitis—Docetaxel—melanoma	0.000892	0.00111	CcSEcCtD
Estazolam—Headache—Docetaxel—melanoma	0.000887	0.0011	CcSEcCtD
Estazolam—Nausea—Docetaxel—melanoma	0.000841	0.00104	CcSEcCtD
Estazolam—Clonazepam—ALB—melanoma	0.000824	0.0329	CrCbGaD
Estazolam—Clobazam—ABCB1—melanoma	0.00069	0.0275	CrCbGaD
Estazolam—Nitrazepam—ABCB1—melanoma	0.00057	0.0227	CrCbGaD
Estazolam—Flurazepam—ABCB1—melanoma	0.000507	0.0202	CrCbGaD
Estazolam—Midazolam—ABCB1—melanoma	0.00047	0.0187	CrCbGaD
Estazolam—Diazepam—ALB—melanoma	0.000422	0.0168	CrCbGaD
Estazolam—Diazepam—ABCB1—melanoma	0.000403	0.0161	CrCbGaD
Estazolam—GABRB3—BDNF signaling pathway—RAC1—melanoma	0.000111	0.00207	CbGpPWpGaD
Estazolam—GABRR1—Transmission across Chemical Synapses—BRAF—melanoma	0.00011	0.00205	CbGpPWpGaD
Estazolam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	0.00011	0.00204	CbGpPWpGaD
Estazolam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	0.00011	0.00204	CbGpPWpGaD
Estazolam—GABRR2—Neuronal System—PRKCA—melanoma	0.00011	0.00204	CbGpPWpGaD
Estazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCA—melanoma	0.000106	0.00196	CbGpPWpGaD
Estazolam—GABRR2—Transmission across Chemical Synapses—BRAF—melanoma	0.000105	0.00196	CbGpPWpGaD
Estazolam—CYP3A4—Tryptophan metabolism—CYP1B1—melanoma	0.000105	0.00195	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—IL10—melanoma	0.000102	0.0019	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000102	0.00189	CbGpPWpGaD
Estazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	0.000101	0.00187	CbGpPWpGaD
Estazolam—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—melanoma	9.94e-05	0.00184	CbGpPWpGaD
Estazolam—GABRB2—Transmission across Chemical Synapses—PRKCA—melanoma	9.92e-05	0.00184	CbGpPWpGaD
Estazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—melanoma	9.72e-05	0.0018	CbGpPWpGaD
Estazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	9.67e-05	0.0018	CbGpPWpGaD
Estazolam—GABRA5—Transmission across Chemical Synapses—PRKCA—melanoma	9.64e-05	0.00179	CbGpPWpGaD
Estazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	9.53e-05	0.00177	CbGpPWpGaD
Estazolam—GABRA3—Transmission across Chemical Synapses—PRKCA—melanoma	9.47e-05	0.00176	CbGpPWpGaD
Estazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—melanoma	9.44e-05	0.00175	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—APC—melanoma	9.42e-05	0.00175	CbGpPWpGaD
Estazolam—GABRA2—Transmission across Chemical Synapses—PRKCA—melanoma	9.3e-05	0.00173	CbGpPWpGaD
Estazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—melanoma	9.27e-05	0.00172	CbGpPWpGaD
Estazolam—GABRR1—Transmission across Chemical Synapses—MDM2—melanoma	9.26e-05	0.00172	CbGpPWpGaD
Estazolam—GABRB3—Transmission across Chemical Synapses—PRKCA—melanoma	9.24e-05	0.00172	CbGpPWpGaD
Estazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—melanoma	9.11e-05	0.00169	CbGpPWpGaD
Estazolam—GABRG2—Transmission across Chemical Synapses—PRKCA—melanoma	9.08e-05	0.00168	CbGpPWpGaD
Estazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—melanoma	9.05e-05	0.00168	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—PRKCA—melanoma	9.03e-05	0.00168	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—PRKCA—melanoma	8.9e-05	0.00165	CbGpPWpGaD
Estazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—melanoma	8.89e-05	0.00165	CbGpPWpGaD
Estazolam—GABRR2—Transmission across Chemical Synapses—MDM2—melanoma	8.83e-05	0.00164	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—SLC5A5—melanoma	8.81e-05	0.00164	CbGpPWpGaD
Estazolam—GABRG3—Transmission across Chemical Synapses—BRAF—melanoma	8.68e-05	0.00161	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—HIF1A—melanoma	8.6e-05	0.0016	CbGpPWpGaD
Estazolam—GABRB1—Transmission across Chemical Synapses—BRAF—melanoma	8.55e-05	0.00159	CbGpPWpGaD
Estazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	8.48e-05	0.00157	CbGpPWpGaD
Estazolam—GABRR1—Neuronal System—BRAF—melanoma	8.47e-05	0.00157	CbGpPWpGaD
Estazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	8.42e-05	0.00156	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—SLC5A5—melanoma	8.4e-05	0.00156	CbGpPWpGaD
Estazolam—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—melanoma	8.36e-05	0.00155	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—MAP2K1—melanoma	8.33e-05	0.00155	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—AKR1B10—melanoma	8.27e-05	0.00154	CbGpPWpGaD
Estazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	8.16e-05	0.00152	CbGpPWpGaD
Estazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	8.14e-05	0.00151	CbGpPWpGaD
Estazolam—GABRR2—Neuronal System—BRAF—melanoma	8.08e-05	0.0015	CbGpPWpGaD
Estazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	8.03e-05	0.00149	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—PRKCA—melanoma	7.93e-05	0.00147	CbGpPWpGaD
Estazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	7.91e-05	0.00147	CbGpPWpGaD
Estazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—melanoma	7.77e-05	0.00144	CbGpPWpGaD
Estazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	7.77e-05	0.00144	CbGpPWpGaD
Estazolam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	7.65e-05	0.00142	CbGpPWpGaD
Estazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	7.63e-05	0.00142	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—PRKCA—melanoma	7.6e-05	0.00141	CbGpPWpGaD
Estazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	7.58e-05	0.00141	CbGpPWpGaD
Estazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	7.45e-05	0.00138	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—PRKCA—melanoma	7.39e-05	0.00137	CbGpPWpGaD
Estazolam—GABRB2—Transmission across Chemical Synapses—BRAF—melanoma	7.31e-05	0.00136	CbGpPWpGaD
Estazolam—GABRG3—Transmission across Chemical Synapses—MDM2—melanoma	7.27e-05	0.00135	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—PRKCA—melanoma	7.25e-05	0.00135	CbGpPWpGaD
Estazolam—GABRB1—Transmission across Chemical Synapses—MDM2—melanoma	7.16e-05	0.00133	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—PRKCA—melanoma	7.13e-05	0.00132	CbGpPWpGaD
Estazolam—GABRA5—Transmission across Chemical Synapses—BRAF—melanoma	7.1e-05	0.00132	CbGpPWpGaD
Estazolam—GABRR1—Neuronal System—MDM2—melanoma	7.09e-05	0.00132	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—PRKCA—melanoma	7.08e-05	0.00131	CbGpPWpGaD
Estazolam—GABRA3—Transmission across Chemical Synapses—BRAF—melanoma	6.97e-05	0.00129	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—PRKCA—melanoma	6.95e-05	0.00129	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—SLC5A5—melanoma	6.92e-05	0.00128	CbGpPWpGaD
Estazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	6.87e-05	0.00128	CbGpPWpGaD
Estazolam—GABRA2—Transmission across Chemical Synapses—BRAF—melanoma	6.85e-05	0.00127	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—SLC5A5—melanoma	6.82e-05	0.00127	CbGpPWpGaD
Estazolam—GABRB3—Transmission across Chemical Synapses—BRAF—melanoma	6.81e-05	0.00126	CbGpPWpGaD
Estazolam—GABRR2—Neuronal System—MDM2—melanoma	6.77e-05	0.00126	CbGpPWpGaD
Estazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	6.76e-05	0.00125	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—ABCB1—melanoma	6.72e-05	0.00125	CbGpPWpGaD
Estazolam—GABRG2—Transmission across Chemical Synapses—BRAF—melanoma	6.68e-05	0.00124	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—BRAF—melanoma	6.65e-05	0.00123	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—CASP3—melanoma	6.64e-05	0.00123	CbGpPWpGaD
Estazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	6.61e-05	0.00123	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—BRAF—melanoma	6.55e-05	0.00122	CbGpPWpGaD
Estazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	6.51e-05	0.00121	CbGpPWpGaD
Estazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	6.51e-05	0.00121	CbGpPWpGaD
Estazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	6.45e-05	0.0012	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—ABCB1—melanoma	6.41e-05	0.00119	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—CTNNB1—melanoma	6.4e-05	0.00119	CbGpPWpGaD
Estazolam—GABRR1—Transmission across Chemical Synapses—MAPK1—melanoma	6.33e-05	0.00117	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—NFKB1—melanoma	6.2e-05	0.00115	CbGpPWpGaD
Estazolam—GABRB2—Transmission across Chemical Synapses—MDM2—melanoma	6.12e-05	0.00114	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—PRKCA—melanoma	6.08e-05	0.00113	CbGpPWpGaD
Estazolam—GABRR2—Transmission across Chemical Synapses—MAPK1—melanoma	6.04e-05	0.00112	CbGpPWpGaD
Estazolam—GABRA5—Transmission across Chemical Synapses—MDM2—melanoma	5.95e-05	0.0011	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—BRAF—melanoma	5.84e-05	0.00108	CbGpPWpGaD
Estazolam—GABRA3—Transmission across Chemical Synapses—MDM2—melanoma	5.84e-05	0.00108	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—SLC5A5—melanoma	5.83e-05	0.00108	CbGpPWpGaD
Estazolam—GABRA2—Transmission across Chemical Synapses—MDM2—melanoma	5.74e-05	0.00107	CbGpPWpGaD
Estazolam—GABRB3—Transmission across Chemical Synapses—MDM2—melanoma	5.7e-05	0.00106	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—SLC5A5—melanoma	5.66e-05	0.00105	CbGpPWpGaD
Estazolam—GABRG2—Transmission across Chemical Synapses—MDM2—melanoma	5.6e-05	0.00104	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—BRAF—melanoma	5.6e-05	0.00104	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—CXCL8—melanoma	5.58e-05	0.00104	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—STAT3—melanoma	5.58e-05	0.00103	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—MDM2—melanoma	5.57e-05	0.00103	CbGpPWpGaD
Estazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	5.57e-05	0.00103	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—SLC5A5—melanoma	5.56e-05	0.00103	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—MDM2—melanoma	5.49e-05	0.00102	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—SLC5A5—melanoma	5.46e-05	0.00101	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—BRAF—melanoma	5.44e-05	0.00101	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—SLC5A5—melanoma	5.43e-05	0.00101	CbGpPWpGaD
Estazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	5.41e-05	0.001	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—CASP3—melanoma	5.34e-05	0.000992	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—BRAF—melanoma	5.34e-05	0.000991	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—SLC5A5—melanoma	5.33e-05	0.000989	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—MAPK3—melanoma	5.33e-05	0.000989	CbGpPWpGaD
Estazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	5.31e-05	0.000986	CbGpPWpGaD
Estazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	5.31e-05	0.000985	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—ABCB1—melanoma	5.28e-05	0.00098	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—BRAF—melanoma	5.25e-05	0.000974	CbGpPWpGaD
Estazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	5.23e-05	0.000971	CbGpPWpGaD
Estazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	5.22e-05	0.000969	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—BRAF—melanoma	5.21e-05	0.000968	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—ABCB1—melanoma	5.2e-05	0.000965	CbGpPWpGaD
Estazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	5.18e-05	0.000962	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—melanoma	5.15e-05	0.000956	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—BRAF—melanoma	5.12e-05	0.00095	CbGpPWpGaD
Estazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	5.09e-05	0.000945	CbGpPWpGaD
Estazolam—GABRR1—Transmission across Chemical Synapses—HRAS—melanoma	5.08e-05	0.000943	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—MAPK1—melanoma	5.07e-05	0.000941	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—NFKB1—melanoma	5e-05	0.000927	CbGpPWpGaD
Estazolam—GABRG3—Transmission across Chemical Synapses—MAPK1—melanoma	4.97e-05	0.000923	CbGpPWpGaD
Estazolam—CYP3A4—Tryptophan metabolism—MDM2—melanoma	4.9e-05	0.00091	CbGpPWpGaD
Estazolam—GABRB1—Transmission across Chemical Synapses—MAPK1—melanoma	4.9e-05	0.000909	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—MDM2—melanoma	4.89e-05	0.000908	CbGpPWpGaD
Estazolam—GABRR1—Neuronal System—MAPK1—melanoma	4.85e-05	0.0009	CbGpPWpGaD
Estazolam—GABRR2—Transmission across Chemical Synapses—HRAS—melanoma	4.85e-05	0.0009	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—MDM2—melanoma	4.69e-05	0.000871	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—SLC5A5—melanoma	4.66e-05	0.000865	CbGpPWpGaD
Estazolam—GABRR2—Neuronal System—MAPK1—melanoma	4.63e-05	0.000859	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—MDM2—melanoma	4.56e-05	0.000846	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—melanoma	4.53e-05	0.000842	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—BRAF—melanoma	4.48e-05	0.000831	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—MDM2—melanoma	4.47e-05	0.000831	CbGpPWpGaD
Estazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	4.47e-05	0.000829	CbGpPWpGaD
Estazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	4.45e-05	0.000826	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—ABCB1—melanoma	4.44e-05	0.000825	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—MDM2—melanoma	4.4e-05	0.000816	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—MDM2—melanoma	4.37e-05	0.000811	CbGpPWpGaD
Estazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	4.34e-05	0.000806	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—CYP17A1—melanoma	4.34e-05	0.000805	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—ABCB1—melanoma	4.32e-05	0.000801	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—MDM2—melanoma	4.29e-05	0.000796	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	4.28e-05	0.000794	CbGpPWpGaD
Estazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	4.26e-05	0.000791	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—ABCB1—melanoma	4.24e-05	0.000787	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—ALB—melanoma	4.2e-05	0.00078	CbGpPWpGaD
Estazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	4.19e-05	0.000778	CbGpPWpGaD
Estazolam—GABRB2—Transmission across Chemical Synapses—MAPK1—melanoma	4.18e-05	0.000777	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—ABCB1—melanoma	4.16e-05	0.000773	CbGpPWpGaD
Estazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	4.16e-05	0.000773	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—ABCB1—melanoma	4.14e-05	0.000768	CbGpPWpGaD
Estazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	4.09e-05	0.000759	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—HRAS—melanoma	4.07e-05	0.000755	CbGpPWpGaD
Estazolam—GABRA5—Transmission across Chemical Synapses—MAPK1—melanoma	4.06e-05	0.000755	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—ABCB1—melanoma	4.06e-05	0.000754	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—ALB—melanoma	4.01e-05	0.000744	CbGpPWpGaD
Estazolam—GABRA3—Transmission across Chemical Synapses—MAPK1—melanoma	3.99e-05	0.000741	CbGpPWpGaD
Estazolam—GABRG3—Transmission across Chemical Synapses—HRAS—melanoma	3.99e-05	0.000741	CbGpPWpGaD
Estazolam—GABRB1—Transmission across Chemical Synapses—HRAS—melanoma	3.93e-05	0.00073	CbGpPWpGaD
Estazolam—GABRA2—Transmission across Chemical Synapses—MAPK1—melanoma	3.92e-05	0.000728	CbGpPWpGaD
Estazolam—GABRB3—Transmission across Chemical Synapses—MAPK1—melanoma	3.9e-05	0.000723	CbGpPWpGaD
Estazolam—GABRR1—Neuronal System—HRAS—melanoma	3.89e-05	0.000723	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—TNF—melanoma	3.89e-05	0.000721	CbGpPWpGaD
Estazolam—GABRG2—Transmission across Chemical Synapses—MAPK1—melanoma	3.83e-05	0.00071	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—MAPK1—melanoma	3.81e-05	0.000707	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—MAPK1—melanoma	3.75e-05	0.000696	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—MDM2—melanoma	3.75e-05	0.000696	CbGpPWpGaD
Estazolam—GABRR2—Neuronal System—HRAS—melanoma	3.71e-05	0.000689	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—CYP1B1—melanoma	3.65e-05	0.000677	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	3.6e-05	0.000668	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—AKT1—melanoma	3.59e-05	0.000667	CbGpPWpGaD
Estazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	3.57e-05	0.000663	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—ABCB1—melanoma	3.55e-05	0.000659	CbGpPWpGaD
Estazolam—GABRB2—Transmission across Chemical Synapses—HRAS—melanoma	3.36e-05	0.000624	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—MAPK1—melanoma	3.35e-05	0.000621	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—ALB—melanoma	3.3e-05	0.000613	CbGpPWpGaD
Estazolam—GABRA5—Transmission across Chemical Synapses—HRAS—melanoma	3.26e-05	0.000606	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—ALB—melanoma	3.25e-05	0.000604	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—MAPK1—melanoma	3.21e-05	0.000595	CbGpPWpGaD
Estazolam—GABRA3—Transmission across Chemical Synapses—HRAS—melanoma	3.2e-05	0.000595	CbGpPWpGaD
Estazolam—GABRA2—Transmission across Chemical Synapses—HRAS—melanoma	3.15e-05	0.000585	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—IL6—melanoma	3.14e-05	0.000582	CbGpPWpGaD
Estazolam—GABRB3—Transmission across Chemical Synapses—HRAS—melanoma	3.13e-05	0.000581	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—MAPK1—melanoma	3.11e-05	0.000578	CbGpPWpGaD
Estazolam—GABRG2—Transmission across Chemical Synapses—HRAS—melanoma	3.07e-05	0.00057	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—MAPK1—melanoma	3.06e-05	0.000568	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—HRAS—melanoma	3.06e-05	0.000568	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—HRAS—melanoma	3.01e-05	0.000559	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—MAPK1—melanoma	3.01e-05	0.000558	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—MAPK1—melanoma	2.99e-05	0.000554	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—MAPK1—melanoma	2.93e-05	0.000544	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—ALB—melanoma	2.78e-05	0.000516	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—ALB—melanoma	2.7e-05	0.000501	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—HRAS—melanoma	2.69e-05	0.000498	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—ALB—melanoma	2.65e-05	0.000492	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—ALB—melanoma	2.61e-05	0.000484	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—ALB—melanoma	2.59e-05	0.00048	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—HRAS—melanoma	2.57e-05	0.000478	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—MAPK1—melanoma	2.56e-05	0.000476	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—ALB—melanoma	2.54e-05	0.000472	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—HRAS—melanoma	2.5e-05	0.000464	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—HRAS—melanoma	2.46e-05	0.000456	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ACER3—melanoma	2.43e-05	0.000452	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—HRAS—melanoma	2.41e-05	0.000448	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—HRAS—melanoma	2.4e-05	0.000445	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—HRAS—melanoma	2.35e-05	0.000437	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—UGT2B10—melanoma	2.23e-05	0.000413	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—ALB—melanoma	2.22e-05	0.000412	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—HS3ST5—melanoma	2.07e-05	0.000384	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—HRAS—melanoma	2.06e-05	0.000382	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PLCB4—melanoma	1.57e-05	0.000291	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SLC6A11—melanoma	1.47e-05	0.000274	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIP4K2A—melanoma	1.47e-05	0.000274	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—MTAP—melanoma	1.43e-05	0.000266	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PHGDH—melanoma	1.28e-05	0.000237	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—LUM—melanoma	1.28e-05	0.000237	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—HPSE—melanoma	1.25e-05	0.000233	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CUBN—melanoma	1.23e-05	0.000228	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CSPG4—melanoma	1.19e-05	0.000221	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—BSG—melanoma	1.19e-05	0.000221	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SDHD—melanoma	1.19e-05	0.000221	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GPAM—melanoma	1.15e-05	0.000214	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PLA2G6—melanoma	9.78e-06	0.000182	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—VCAN—melanoma	8.79e-06	0.000163	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP17A1—melanoma	7.42e-06	0.000138	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GNA11—melanoma	7e-06	0.00013	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—FASN—melanoma	6.85e-06	0.000127	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SLC5A5—melanoma	6.74e-06	0.000125	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GNAQ—melanoma	6.51e-06	0.000121	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CD44—melanoma	6.51e-06	0.000121	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP1B1—melanoma	6.24e-06	0.000116	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ABCB1—melanoma	5.14e-06	9.54e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PRKCA—melanoma	4.73e-06	8.78e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ERCC2—melanoma	4.69e-06	8.71e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CG—melanoma	3.71e-06	6.88e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PPARG—melanoma	3.58e-06	6.64e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CD—melanoma	3.26e-06	6.05e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ALB—melanoma	3.22e-06	5.97e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CB—melanoma	2.84e-06	5.27e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PTGS2—melanoma	2.81e-06	5.22e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PTEN—melanoma	2.45e-06	4.55e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CA—melanoma	1.73e-06	3.21e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—AKT1—melanoma	1.41e-06	2.62e-05	CbGpPWpGaD
